Dermatology

>

Latest News

FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves dupilumab for chronic spontaneous urticaria in ages 12 and up

April 18th 2025

The sBLA for dupilumab (Dupixent) was supported by data from the phase 3 LIBERTY-CUPID clinical program in patients with uncontrolled CSU.

FDA approves maralixibat tablet formulation for ALGS and PFIC | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves maralixibat tablet formulation for ALGS and PFIC

April 14th 2025

JNJ-2113 for plaque psoriasis demonstrates clear skin in 75% of adolescents | Image Credit: © Ban - © Ban - stock.adobe.com.
JNJ-2113 for plaque psoriasis demonstrates clear skin in 75% of adolescents

April 10th 2025

Uncharacteristic skin findings in a toddler with a history of dermatitis
Uncharacteristic skin findings in a toddler with a history of dermatitis

April 8th 2025

Full case: 21-month-old with history of “skin tags” on her gluteal cleft |  Image Credit: © Daqota - © Daqota - stock.adobe.com.
Full case: 21-month-old with history of “skin tags” on her gluteal cleft

April 4th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.